Ann Merchant
Director/Board Member at ALVOTECH
Net worth: 129 312 $ as of 2024-03-30
Profile
Ann Merchant is currently a Non-Executive Director at Biodexa Pharmaceuticals Plc and a Director at Alvotech hf.
She is also an Independent Non-Executive Director at Alvotech since 2022.
Previously, she held the position of Vice President & Head-Global Supply Chain at MorphoSys AG starting in 2018.
Prior to that, Ms. Merchant worked at Amgen, Inc. as the Head-International Supply Chain & Site Head from 1994 to 2011.
She then served as the President of Schreiner Medipharm from 2011 to 2018.
Ms. Merchant holds an MBA from Henley Business School Ltd.
and an undergraduate degree from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALVOTECH
0.00% | 2024-02-14 | 10,582 ( 0.00% ) | 129 312 $ | 2024-03-30 |
Ann Merchant active positions
| Companies | Position | Start |
|---|---|---|
| ALVOTECH | Director/Board Member | 2022-06-15 |
| MORPHOSYS AG | Corporate Officer/Principal | 2017-12-31 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 2023-12-30 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Director/Board Member | - |
Former positions of Ann Merchant
| Companies | Position | End |
|---|---|---|
| Schreiner Medipharm | President | 2018-07-31 |
| AMGEN INC. | Corporate Officer/Principal | 2010-12-31 |
Training of Ann Merchant
| Henley Business School Ltd. | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| ALVOTECH | Health Technology |
| Private companies | 2 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
| Schreiner Medipharm |
- Stock Market
- Insiders
- Ann Merchant
